Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab–Bevacizumab
Anticancer Research · 2026
DOI: 10.21873/anticanres.18056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Hisanori Muto und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan; hisanori.muto@fujita-hu.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Phenylurea Compounds, Liver Neoplasms, Quinolines.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan; hisanori.muto@fujita-hu.ac.jp.
- Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
- Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
- Department of Gastroenterology, Fujita Health University Okazaki Medical Center, Okazaki, Japan.
- Department of Advanced Endoscopy, Fujita Health University, Toyoake, Japan.
Zitieren
APA
Muto, H., Kuzuya, T., Tachi, Y., Nagano, Y., Kajino, Y., Matsushita, M., Hagihara, S., Yamamoto, S., Kobayashi, T., Katano, Y., Ohmiya, N., Hashimoto, S., Ariga, M., Morisaki, S., Komura, G., Nakano, T., Tanaka, H., Nakaoka, K., Ohno, E., …, & Hirooka, Y. (2026). Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab–Bevacizumab. Anticancer Research. https://doi.org/10.21873/anticanres.18056
Vancouver
Muto H, Kuzuya T, Tachi Y, Nagano Y, Kajino Y, Matsushita M, et al. Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab–Bevacizumab. Anticancer Research. 2026. doi:10.21873/anticanres.18056
BibTeX
@article{Muto2026,
author = {Muto, Hisanori and Kuzuya, Teiji and Tachi, Yoshihiko and Nagano, Yosuke and Kajino, Yutaro and Matsushita, Misae and Hagihara, Seiya and Yamamoto, Satoshi and Kobayashi, Takashi and Katano, Yoshiaki and Ohmiya, Naoki and Hashimoto, Senju and Ariga, Mizuki and Morisaki, Sayaka and Komura, Gakushi and Nakano, Takuji and Tanaka, Hiroyuki and Nakaoka, Kazunori and Ohno, Eizaburo and Funasaka, Kohei and Nagasaka, Mitsuo and Miyahara, Ryoji and Hirooka, Yoshiki},
title = {Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab–Bevacizumab},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18056}
}
EUVIMED